Myanmar vs United Arab Emirates: Reported versus estimated cases of polio
Myanmar
0 cases
in 2023
United Arab Emirates
0 cases
in 2023
Myanmar rank
26th
United Arab Emirates rank
26th
Reported versus estimated cases of polio over time
- Myanmar
- United Arab Emirates
How they compare
Myanmar currently reports 0 cases against 0 cases in United Arab Emirates, a difference of 0 cases.
The two have swapped places 7 times across 43 shared years of data; in 1980 it was Myanmar ahead.
Myanmar ranks 26th and United Arab Emirates ranks 26th of 199 countries.
Myanmar has averaged higher in every one of the 5 decades both report.
Head to head by decade
| Decade | Myanmar | United Arab Emirates | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 169.56 cases | 22.11 cases | 147.44 cases | Myanmar |
| 1990s | 40.3 cases | 0.2 cases | 40.1 cases | Myanmar |
| 2000s | 6 cases | 0 cases | 6 cases | Myanmar |
| 2010s | 0.8 cases | 0 cases | 0.8 cases | Myanmar |
| 2020s | 0 cases | 0 cases | 0 cases | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported versus estimated cases of polio, Myanmar or United Arab Emirates?
- Myanmar, at 0 cases against 0 cases in United Arab Emirates as of 2023.
- What is the difference in reported versus estimated cases of polio between Myanmar and United Arab Emirates?
- 0 cases, with Myanmar ahead.
- How many years of comparable data are there for Myanmar and United Arab Emirates?
- 43 years are reported by both, from 1980 to 2023.
- How do Myanmar and United Arab Emirates rank globally for reported versus estimated cases of polio?
- Myanmar ranks 26th and United Arab Emirates ranks 26th of 199 countries.
- Where does this data come from?
- World Health Organization (2019); World Health Organization (2024) – processed by Our World in Data, published as Reported versus estimated cases of polio. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Sum of wild poliovirus cases and circulating vaccine derived poliovirus cases.